Impax Asset Management Group PLC Travere Therapeutics, Inc. Transaction History
Impax Asset Management Group PLC
- $14.9 Billion
- Q1 2025
A detailed history of Impax Asset Management Group PLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Impax Asset Management Group PLC holds 300,000 shares of TVTX stock, worth $4.32 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
300,000
Previous 300,000
-0.0%
Holding current value
$4.32 Million
Previous $5.23 Million
2.87%
% of portfolio
0.04%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding TVTX
# of Institutions
239Shares Held
99.9MCall Options Held
1.79MPut Options Held
555K-
Armistice Capital, LLC New York, NY8.87MShares$128 Million2.42% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$110 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X07.53MShares$108 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.01MShares$72.3 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.8MShares$69.1 Million0.11% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $925M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...